Lyme borreliosis: Current issues in diagnosis and management

Current Opinion in Infectious Diseases

Volumn 23, Issue 3, 2010, Pages 231-235

  O'Connell, Sue ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diagnosis; Lyme borreliosis; Management; Neuroborreliosis

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; DOXYCYCLINE; PENICILLIN G; PENICILLIN V;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; DIAGNOSTIC TEST; DRUG EFFICACY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; REVIEW; SEROLOGY;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DOXYCYCLINE; HUMANS; INCIDENCE; LYME DISEASE; SEROLOGIC TESTS;

EID: 77951621109     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32833890e2     Document Type: Review

References (31)

1. Elston DM. Tick bites and skin rashes. Curr Opin Infect Dis 2010; 23:132-138.
2. Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro Surveill 2006; 11:E0606221.
3. Fülöp B, Poggensee G. Epidemiological situation of Lyme borreliosis in Germany: surveillance data from six Eastern German States, 2002 to 2006. Parasitol Res 2008; 103 (Suppl 1):S117-S120.
4. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease: United States-1992-2006. MMWR Surveill Summ 2008; 57:1-9.
5. Ogden NH, St Onge L, Barker IK, et al. Risk maps for range expansion of the Lyme disease vector in Canada now and with climate change. Int J Health Geogr 2008; 7:24. doi: 10.1186/1476-072X-7-24.
6. Gray JS, Dautel H, Estrada-Pena A, et al. Effects of climate change on ticks and tickborne diseases in Europe. Interdiscip Perspect Infect Dis 2009; doi: 10.1155/2009/593232.
7. Stanek G, Strle F. Lyme disease: European perspective. Infect Dis Clin N Am 2008; 22:327-339.
8. Stanek G, Strle F. Lyme borreliosis: a European perspective on diagnosis and management. Curr Opin Infect Dis 2009; 22:450-454.
9. Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin N Am 2008; 22:235-260.
10. Aucott J, Morrison C, Munoz B, et al. Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis 2009; 9:79. doi: 10.1186/1471-2334-9-79.
11. Costello JM, Alexander ME, Greco JM, et al. Lyme carditis in children: presen-tation, predictive factors and clinical course. Pediatrics 2009; 123:e835-e841.
12. Cerar D, CerarT, Ruzic-Sabljic E, et al. Subjective symptoms after treatment · of early Lyme disease. Am J Med 2010; 123:79-86.
13. Halperin JJ. Nervous system Lyme disease. Infect Dis Clin N Am 2008; 22:261-274.
14. Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2010 doi:10.1111/j.1469-0691.2010.031 75x [Epub ahead of print].
15. OymarK,TveitnesD. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis 2009; 41:88-94.
16. Tveitnes D, Oymar K, Natas O. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis 2009; 41:355-362.
17. Skogman BH, Croner S, Nordwall M, et al. Lyme neuroborreliosis in children. A prospective study of clinical features, prognosis and outcome. Pediatr Infect Dis J 2008; 27:1089-1094.
18. Tuerlinckx D, Bodart E, Jamart J,Glupczynski Y. Prediction of Lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis. Pediatr Infect Dis J 2009; 28:394-397.
19. Avery RA, Frank G, Glutting J, Eppes SC. Prediction of Lyme meningitis in children from a Lyme-disease endemic region: a logistic regression model using history, physical and laboratory findings. Pediatrics 2006; 117:e1-e7.
20. Nigrovic LE, Thompson AD, Fine AM, Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an Emergency Department in a Lyme disease-endemic area. Pediatrics 2008; 122:e1080-e1085.
21. Huttonen P, Lappalainen M, Salo E, et al. Differential diagnosis of acute central nervous system infections using modern microbiological methods. Acta Paediatr 2009; 98:1300-1306.
22. Rupprecht T, Koedel U, Fingerle V, Pfister H-W. The pathogenesis of Lyme borreliosis: from infection to inflammation. Mol Med 2008; 14:205-212.
23. Ljostad U, Skogvall E, Eikeland R, et al. Oral doxycycline versus intravenous · ceftriaxone for the treatment of European Lyme neuroborreliosis: a multi-centre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008; 7:690-695.
24. Ljostad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis: frequency, pattern and risk factors. Eur J Neurol 2010; 17:118-123.
25. Henningsson AJ, Malmvall B-E, Ernerudh J, et al. Neuroborreliosis: an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 2009. doi:10.1111/j.1469-0691.2009. 03059 [Epub ahead of print].
26. Marques A. Chronic Lyme disease: a review. Infect Dis Clin N Am 2008;22:341-360.
27. Hassett AL, Radvanski DC, Buyske S, et al. Psychiatric co-morbidity and other psychological factors in patients with 'chronic Lyme disease'. Am J Med 2009; 122:843-850.
28. Health Protection Agency. http://www.hpa.org.uk/webw/ HPAweb&HPAwebStandard/HPAweb-C/1195733785275?p=1191942172156. [Accessed 24 January 2010]
29. Mygland A, Ljostad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. EurJ Neurol 2010; 17:8-16.
30. The ALSUntangled Group. ALSUntangled Update 1: investigating a bug (Lyme disease) and a drug (Iplex) on behalf of people with ALS. Amyotrophic Lateral Sclerosis 2009; 10:248-250.
31. Qureshi M, Bedlack RS, Cudkowicz ME. Lyme disease serology in amyotrophic lateral sclerosis. Muscle Nerve 2009; 40:626-628.